A Step Towards Tuberculosis Elimination ? Advantages of Pretomanid Use in MDR-TB Patients - Amsterdam 2025

Pulmonary and extrapulmonary tuberculosis: clinical management

Chair(s): Christoph Lange, Mirae Park

Session type: Poster session

A Step Towards Tuberculosis Elimination ? Advantages of Pretomanid Use in MDR-TB Patients

Aysel Aslanova

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Risk factors and treatment outcomes of drug-resistant Tuberculosis in migrants

Giovanni Fumagalli

Poster

Abstract

Prevalence and short-term outcomes of acute complications of tuberculosis: a cross-sectional, monocentre, Italian study.

Sara Maggioni

Poster

Abstract

Predictive factors of time to sputum culture conversion in multidrug-resistant tuberculosis

Mayssa Chariag

Poster

Abstract

Identification of Pretomanid drug resistance in clinical isolates of Multi-Drug Resistant (MDR) Mycobacterium tuberculosis from North India

Roopendra Kumar

Poster

Abstract

Endobronchial Tuberculosis:- Is surveillance bronchoscopy the missing link!!

Sourabh Pahuja

Abstract

Ukraine's experience in rapid implementation of innovative short treatment regimens for DR-TB

Olesia Medvedieva

Poster

Abstract

Cardiovascular risks of bedaquiline use in patients with drug-resistant tuberculosis

Olha Molodovets

Poster

Abstract

Effectiveness of BPaL and BPaL/M short treatment regimens for DR-TB patients in Azerbaijan

Gulzar Aliyeva

Poster

Abstract

A Step Towards Tuberculosis Elimination Advantages of Pretomanid Use in MDR-TB Patients

Aysel Aslanova

Abstract

Risk factors and causes of treatment failures in drug-susceptible tuberculosis in Lithuania over 22 years

Karolina Kevelaitiene

Poster

Abstract

Mortality and multiresistant pulmonary tuberculosis in Abidjan, Ivory Coast.

Prowo Thiffany

Abstract

Therapeutic Stratification in MDR-TB: A 16.3% Efficacy Gap Between Treatment-Naïve and Retreated Patients in Urban China

Yidian Liu

Poster

Abstract

Treatment success and predictors of unfavorable outcomes in isoniazid-monoresistant tuberculosis: A single-center retrospective cohort study in Malaysia

Tee Sunn Ren

Poster

Abstract

Correlation between serum isoniazid concentration and therapeutic response in pulmonary tuberculosis

Roumaissa Bellara

Poster

Abstract

Post-treatment outcomes three years after a 9-month regimen for rifampicin-resistant tuberculosis in Vietnam

Thi Mai Phuong Nguyen

Poster

Abstract

Risk factors associated with drug-induced hepatoxicity (DIH) with antituberculosis medications among tuberculosis directly observed treatment short-course (TB-DOTS) patients in a tertiary hospital

Michael Gino Ordoña

Poster

Abstract

Adverse effects of anti-TB treatment in MDR-TB patients among different regimens

Atefeh Fakharian

Poster

Abstract

Late Breaking Abstract - Previous pulmonary TB as a risk factor for lung functional impairment: a cross-sectional study in a rural area of Senegal

Irene Sini

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}